NCT07155707 Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
| NCT ID | NCT07155707 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 156 participants |
| Start Date | 2026-06-24 |
| Primary Completion | 2027-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 156 participants in total. It began in 2026-06-24 with a primary completion date of 2027-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with a mood and/or anxiety disorder * Have proficiency to participate in psychotherapy in English * Scheduled to begin therapy at one of the study sites * RCADS score \> 65 Exclusion Criteria: \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Contact & Investigator
David S Hong, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07155707 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 14 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07155707 currently recruiting?
Yes, NCT07155707 is actively recruiting participants. Contact the research team at barreraj@stanford.edu for enrollment information.
Where is the NCT07155707 trial being conducted?
This trial is being conducted at Monterey, United States, Stanford, United States.
Who is sponsoring the NCT07155707 clinical trial?
NCT07155707 is sponsored by Stanford University. The principal investigator is David S Hong, MD at Stanford University. The trial plans to enroll 156 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.